Abstract:Gene therapy has long been regarded a promising treatment for many diseases, whether acquired (such as AIDS or cancer) or inherited through a genetic disorder. A drug based on a nucleic acid, however, must be delivered to the interior of the target cell while surviving an array of biological defenses honed by evolution. Successful gene therapy is thus dependent on the development of an efficient delivery vector. Researchers have pursued two major vehicles for gene delivery: viral and nonviral (synthetic) vectors. Although viral vectors currently offer greater efficiency, nonviral vectors, which are typically based on cationic lipids or polymers, are preferred because of safety concerns with viral vectors. So far, nonviral vectors can readily transfect cells in culture, but efficient nanomedicines remain far removed from the clinic. Overcoming the obstacles associated with nonviral vectors to improve the delivery efficiency and therapeutic effect of nucleic acids is thus an active area of current research. The difficulties are manifold, including the strong interaction of cationic delivery vehicles with blood components, uptake by the reticuloendothelial system (RES), toxicity, and managing the targeting ability of the carriers with respect to the cells of interest. Modifying the surface with poly(ethylene glycol), that is, PEGylation, is the predominant method used to reduce the binding of plasma proteins to nonviral vectors and minimize clearance by the RES after intravenous administration. Nanoparticles that are not rapidly cleared from the circulation accumulate in the tumors because of the enhanced permeability and retention effect, and the targeting ligands attached to the distal end of the PEGylated components allow binding to the receptors on the target cell surface. Neutral and anionic liposomes have been also developed for systemic delivery of nucleic acids in experimental animal models. Other approaches include (i) designing and synthesizing novel cationic lipids and polymers, (ii) chemically coupling the nucleic acid to peptides, targeting ligands, polymers, or environmentally sensitive moieties, and (iii) utilizing inorganic nanoparticles in nucleic acid delivery. Recently, the different classes of nonviral vectors appear to be converging, and the ability to combine features of different classes of nonviral vectors in a single strategy has emerged. With the strengths of several approaches working in concert, more hurdles associated with efficient nucleic acid delivery might therefore be overcome. In this Account, we focus on these novel nonviral vectors, which are classified as multifunctional hybrid nucleic acid vectors, novel membrane/core nanoparticles for nucleic acid delivery, and ultrasound-responsive nucleic acid vectors. We highlight systemic delivery studies and consider the future prospects for nucleic acid delivery. A better understanding of the fate of the nanoparticles inside the cell and of the interactions between the parts of hybrid particles should lead to a delivery system suitable for clinical use. We also underscore the value of sustained release of a nucleic acid in this endeavor; making vectors targeted to cells with sustained release in vivo should provide an interesting research challenge.

Dual-Functionalized Covalent Triazine Framework Nanosheets As Hierarchical Nonviral Vectors for Intracellular Gene Delivery

Polymeric Nanostructure Compiled with Multifunctional Components to Exert Tumor-Targeted Delivery of Antiangiogenic Gene for Tumor Growth Suppression

Protein nanocapsules based vectors for efficient gene transfection

Responsive Cationic Polymer and Cationic Nanomicelle Vectors for Gene Delivery

Single cyclized molecule versus single branched molecule: a simple and efficient 3D "knot" polymer structure for nonviral gene delivery.

Highly Branched Poly Β-Amino Ester/cpg-Depleted CFTR Plasmid Nanoparticles for Non-viral Gene Therapy in Lung Cystic Fibrosis Disease

Nonviral Cancer Gene Therapy: Delivery Cascade and Vector Nanoproperty Integration.

Beyond Branching: Multiknot Structured Polymer for Gene Delivery

Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks

Functional and Biodegradable Dendritic Macromolecules with Controlled Architectures As Nontoxic and Efficient Nanoscale Gene Vectors.

Delivery of Surface-Mediated Non-Viral Gene Nanoparticles from Ultrathin Layer-by-layer Multilayers

Self-assembled supramolecular nano vesicles for safe and highly efficient gene delivery to solid tumors

Virus-Inspired Self-Assembled Nanofibers with Aggregation-Induced Emission for Highly Efficient and Visible Gene Delivery

A new pathway for developing in vitro nanostructured non-viral gene carriers

Nucleobase-modified Dendrimers As Nonviral Vectors for Efficient and Low Cytotoxic Gene Delivery.

Enhanced nuclear gene delivery via integrating and streamlining intracellular pathway

Recent advances in nonviral vectors for gene delivery

Efficient, Dual-Stimuli Responsive Cytosolic Gene Delivery Using a RGD Modified Disulfide-Linked Polyethylenimine Functionalized Gold Nanorod.

The construction of a novel kind of non-viral gene delivery vector based on protein as core backbone.

Polymer-functionalized Nanodiamond Platforms As Vehicles for Gene Delivery.

Emerging non-viral vectors for gene delivery